STAAR Surgical Company EPS (Earnings per Share) 2010–2025
STAAR Surgical Company reported $-1.62 of earnings per share for fiscal 2025. That was 295.1% lower than fiscal 2024. Compared with fiscal 2020, the change was -640.0%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $-1.62 | -295.1% |
| FY 2024 | $-0.41 | -195.3% |
| FY 2023 | $0.43 | -46.3% |
| FY 2022 | $0.80 | +42.9% |
| FY 2021 | $0.56 | +366.7% |
| FY 2021 | $0.12 | -60.0% |
| FY 2020 | $0.30 | +172.7% |
| FY 2018 | $0.11 | +320.0% |
| FY 2017 | $-0.05 | +83.3% |
| FY 2016 | $-0.30 | -76.5% |
| FY 2016 | $-0.17 | +22.7% |
| FY 2015 | $-0.22 | -2300.0% |
| FY 2014 | $0.01 | +120.0% |
| FY 2012 | $-0.05 | -225.0% |
| FY 2011 | $0.04 | — |
| FY 2010 | $0.00 | +100.0% |
| FY 2010 | $-0.19 | — |
Source: STAAR Surgical Company SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open STAA 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
STAAR Surgical Company reported $-1.62 of earnings per share for fiscal 2025. That was 295.1% lower than fiscal 2024. Compared with fiscal 2020, the change was -640.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for STAAR Surgical Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSTAAR Surgical Company — frequently asked questions
What is STAAR Surgical Company's earnings per share?
STAAR Surgical Company (STAA) reported earnings per share of $-1.62 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from STAAR Surgical Company's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.